| ²é¿´: 7036 | »Ø¸´: 173 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
lwjxzľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
|
[×ÊÔ´]
¹ã¶«Ê¡µÚÒ»ÆÚÒ©Æ·×¢²áÉ걨ÈËÔ±Ìá¸ß°à--Åàѵ½Ì²Ä2011.11.pdf
|
||
|
ÏÂÔØ£ºhttp://ishare.iask.sina.com.cn/f/23007422.html Ŀ¼£º 1¡¢ Éú²úÏÖ³¡¼ì²é±¨¸æ/ÑùÆ·¼ìÑé»·½Ú 2¡¢ Ò©Æ·×¢²áÏÖ³¡ºË²éÎÊÌâ·ÖÎö 3¡¢ Å·ÃÀ£¨ÔÁÏÒ©£©×¢²á£ºCTD¸ñʽÉ걨¾Ñé½»Á÷ 4¡¢ Ò©Æ·×¢²áÉóÆÀ°¸Àý·ÖÎö 5¡¢ »¯Ñ§Ò©Ò©Ñ§×ÊÁÏCTD¸ñʽµç×ÓÎļþÎĵµ±ê×¼ºÍÉ걨×ÊÁϵÄÌåÀýÓëÕûÀí¹æ·¶ 6¡¢ Drug Safety and Quality Enforcement£ºChallenges and Solutions |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ¹ã¶«Ê¡µÚÒ»ÆÚÒ©Æ·×¢²áÉ걨ÈËÔ±Ìá¸ß°à--Åàѵ½Ì²Ä2011.11.pdf
2012-02-06 14:54:36, 4.15 M
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
211¸ßУ2026ÄêÈëѧ²©Ê¿Ãû¶î
ÒѾÓÐ16È˻ظ´
º£²ªÔ¸¨ÁÏÖúÁ¦ÒøÐ¼²¡Ò»ÏßÍâÓÃÖÆ¼Á¿ª·¢
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ112È˻ظ´
¶þÒÒÏ©»ùí¿µÄºÏ³É·¾¶
ÒѾÓÐ4È˻ظ´
ÇóÒ»Öê[b]ÇóýMTAP(human)µÄHCT-116(È˽᳦°©Ï¸°û)/b]ϸ°û
ÒѾÓÐ0È˻ظ´
ÇóÖú£¡ÇóÃÀ¹úʳƷ»¯Ñ§Ò©µäÄÚÈÝ£ºFCC13¡¾µÍ¾Û¹ûÌÇרÂÛ¡¿
ÒѾÓÐ0È˻ظ´
¡¾2027²©Ê¿ÉêÇë¡¿ÄÉÃ×Ò©ÎïµÝËÍ·½Ïò
ÒѾÓÐ5È˻ظ´
ÏûºÄ΢Á¿API£¬±ã¿ÉÔ¤²âÔçÆÚÑз¢½×¶ÎµÄHME¹¤ÒÕ¿ÉÐÐÐÔ
ÒѾÓÐ0È˻ظ´
·´Ó¦ÒºÖб½ôû³ýÈ¥
ÒѾÓÐ1È˻ظ´
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
101Â¥2013-02-06 14:57:01
3Â¥2012-02-06 16:27:30
7Â¥2012-02-06 17:19:44
13Â¥2012-02-07 11:08:59
¼òµ¥»Ø¸´
lmluky4Â¥
2012-02-06 16:39
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
lsf00018Â¥
2012-02-06 22:18
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
aguang_20119Â¥
2012-02-07 00:04
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
oleland882610Â¥
2012-02-07 08:48
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wangcaihao11Â¥
2012-02-07 08:59
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
mslab12Â¥
2012-02-07 09:15
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
surge200714Â¥
2012-02-07 11:26
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡









»Ø¸´´ËÂ¥
¸Ã¸ÉÂï¸ÉÂïÈ¥
·Ç³£¸Ðл
ͶƱ: